You are here

Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Ann Arbor, Michigan, 48105 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Obesity
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- No clinically relevant abnormalities based upon medical history, physical exam,
12-lead ECG, and clinical lab tests

- Body Mass Index (BMI) ~ 27-40 kg/m2, inclusive

- Personally signed inform consent document

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence or history of significant acute or chronic disease

- Pregnant or nursing females

- Screening PR interval > 220 msec

- Sitting blood pressure

NCT00645463
Pfizer
Completed
Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now